Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Chris Lange | Feb 11, 2015 at 9:40 AM EST

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech…

Lee Jackson | Feb 3, 2015 at 9:25 AM EST

Portfolio Managers Love These 5 Biotech Stocks

Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.

Chris Lange | Jan 29, 2015 at 10:45 AM EST

Is Celgene’s Outlook Good Enough for Investors?

Celgene Corp. (NASDAQ: CELG) reported better-than-expected fourth-quarter earnings on Thursday morning.

Chris Lange | Jan 28, 2015 at 11:00 AM EST

Short Sellers Starting to Gang Up on Biotech

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected…

Chris Lange | Jan 13, 2015 at 8:55 AM EST

Short Interest in Biotechs Signals Optimism

24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.

Chris Lange | Jan 12, 2015 at 12:10 PM EST

Celgene Expects to More Than Triple Earnings by 2020

Celgene Corp. provided a preliminary look at its financials for 2014 but also gave its financial outlook for 2015 and…

Chris Lange | Jan 7, 2015 at 2:51 PM EST

Wells Fargo’s Top Biotech Stocks for 2015

ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech…

Jon C. Ogg | Jan 1, 2015 at 9:15 AM EST

5 Massive Upside Stocks for 2015

24/7 Wall St. wanted to see which analyst picks in mid-cap to large-cap stocks offer the most upside. Some of…

Lee Jackson | Dec 23, 2014 at 9:50 AM EST

RBC’s 5 Top Biotech Stocks to Buy for 2015

One sector that could be poised to do well could be the biotech arena, and the team at RBC has…

Chris Lange | Dec 19, 2014 at 2:58 PM EST

Merrill Lynch’s Top Health Care Stock Picks for 2015

24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.

Chris Lange | Dec 10, 2014 at 10:00 AM EST

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top…

Jon C. Ogg | Dec 9, 2014 at 8:25 AM EST

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Tuesday's top analyst upgrades and downgrades from 24/7 Wall St. include Cisco Systems, Dreamworks Animation, Lululemon Athletica, Schlumberger and Verizon…

Chris Lange | Nov 26, 2014 at 11:07 AM EST

Mixed Readings For Biotech Short Interest

ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of…

Lee Jackson | Nov 25, 2014 at 8:40 AM EST

RBC Has Three Top Biotech Picks for Year End and 2015

ThinkstockIf any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the…

Chris Lange | Nov 12, 2014 at 8:40 AM EST

Biotech Short Interest Becomes Stock Specific (Updated)

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.

1 … 17 18 19 20 21 … 29

Celgene : CELG

All CELG Articles

Short Sellers Look Scared of Big Biotech

Portfolio Managers Love These 5 Biotech Stocks

Is Celgene’s Outlook Good Enough for Investors?

Short Sellers Starting to Gang Up on Biotech

Short Interest in Biotechs Signals Optimism

Celgene Expects to More Than Triple Earnings by 2020

Wells Fargo’s Top Biotech Stocks for 2015

5 Massive Upside Stocks for 2015

RBC’s 5 Top Biotech Stocks to Buy for 2015

Merrill Lynch’s Top Health Care Stock Picks for 2015

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Mixed Readings For Biotech Short Interest

RBC Has Three Top Biotech Picks for Year End and 2015

Biotech Short Interest Becomes Stock Specific (Updated)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Celgene : CELG

All CELG Articles

Short Sellers Look Scared of Big Biotech

Portfolio Managers Love These 5 Biotech Stocks

Is Celgene’s Outlook Good Enough for Investors?

Short Sellers Starting to Gang Up on Biotech

Short Interest in Biotechs Signals Optimism

Celgene Expects to More Than Triple Earnings by 2020

Wells Fargo’s Top Biotech Stocks for 2015

5 Massive Upside Stocks for 2015

RBC’s 5 Top Biotech Stocks to Buy for 2015

Merrill Lynch’s Top Health Care Stock Picks for 2015

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Mixed Readings For Biotech Short Interest

RBC Has Three Top Biotech Picks for Year End and 2015

Biotech Short Interest Becomes Stock Specific (Updated)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%